Full Text View
Tabular View
No Study Results Posted
Related Studies
Dextromethorphan to Treat Patients With Voice Spasms
This study has been completed.
Study NCT00055549   Information provided by National Institutes of Health Clinical Center (CC)
First Received: March 5, 2003   Last Updated: November 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Voice Disorders
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Laryngeal Diseases
Nervous System Diseases
Neurologic Manifestations
Otorhinolaryngologic Diseases
Pathologic Processes
Respiratory Tract Diseases
Signs and Symptoms
Interventions listed in this trial
Dextromethorphan
Lorazepam
More general drug interventions related to this trial
Anti-Anxiety Agents
Anticonvulsants
Antiemetics
Antitussive Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
GABA Agents
GABA Modulators
Gastrointestinal Agents
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Respiratory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services